基因组甲基转移酶SMYD2:对癌症和与衰老相关的疾病治疗的潜在药理目标
Meng Gu1, Menglin Zhu1, Jianghong Cai1
1Laboratory of Drug Discovery from Natural Resources and Industrialization, Macao University of Science and Technology, Macau SAR, 999078, China.
European journal of medicinal chemistry
|February 3, 2026
概括
蛋白质甲基化异常与疾病有关. 这篇评论探讨了SMYD2的情况.
科学领域:
- 表观遗传学和分子生物学.
- 癌症生物学和衰老研究.
背景情况:
- 蛋白质甲基化在疾病发病过程中至关重要.
- SMYD2 (含有SET和MYND域的蛋白-2) 与癌症和衰老有关.
- SMYD2的精确生物作用和抑制剂的发展需要进一步的研究.
研究的目的:
- 审查SMYD2在癌症和衰老中的机制.
- 为了澄清SMYD2抑制剂对各种疾病的影响.
- 确定研究缺口,并提出SMYD2抑制剂开发的未来方向.
主要方法:
- 对SMYD研究的文献综述2.
- 分析SMYD2在癌症和衰老中的作用.
- 评估现有的SMYD2抑制剂及其疗效.
主要成果:
- SMYD2是癌症和与衰老相关的疾病的关键参与者.
- 特定的SMYD2抑制剂显示出治疗潜力.
- 当前研究中的相互矛盾的发现凸显了进一步研究的必要性.
结论:
- SMYD2是癌症和衰老的有前途的治疗点.
- 进一步研究SMYD2结构和抑制剂的发展是有必要的.
- 本综述为新药开发策略提供了见解.
相关概念视频
Histone Modification
16.2K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.2K
Histone Variants at the Centromere
5.1K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
956
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
956
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Inflammatory Bowel Disease IV: Pharmacological Management
617
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
617


